Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Schlafen family member 12-like (SLFN12L) is an intermediate member of the human Schlafen family of proteins, predicted to be membrane-associated and structurally related to the murine Slfn4 protein[1][3]. The Schlafen family is characterized by shared N-, M-, and C-terminal domains and functions in immunity, cell differentiation, and potentially cancer biology[3]. SLFN12L has been associated with the regulation of immune homeostasis, specifically influencing lymphocyte subsets such as natural killer cells[1]. During chronic Helicobacter pylori infection, SLFN12L marks a population of myeloid-derived suppressor cells migrating to the gastric mucosa and is linked to preneoplastic transformation, suggesting a role in cancer development[1][3]. Although related proteins in the Schlafen family (notably SLFN12) have recognized roles in tumor differentiation, drug resistance, and immune regulation, SLFN12L itself has not been conclusively linked to any currently targeted therapeutic pathway nor to approved or investigational drugs[3]. The specific molecular mechanisms and clinical significance of SLFN12L are not well established and remain an active area of research[1][3]. Important clarification: - "SLFN5" is not an alias for SLFN12L; it is a separate long Schlafen family member[3], and any sources treating these as identical should be disregarded as incorrect. - Humans express both intermediate (SLFN12, SLFN12L) and long (e.g., SLFN5) Schlafen proteins, but SLFN12L is always distinct from SLFN5[2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Schlafen family member 12-like (SLFN12L).